Uroscan 76 Injection

Overview Uroscan 76 Injection

NephroView 76 Injection combines two radiopaque contrast agents for diagnostic imaging. This injectable medication facilitates visualization of internal organs and their function, aiding precise diagnoses and potential disease prevention. Administration should be exclusively by qualified medical personnel under physician direction. While temporary pain and irritation are possible, these side effects are typically self-limiting. Prior to administration, complete disclosure of any pre-existing conditions, including cardiac, hepatic, or renal disease, is crucial. Pregnant or lactating individuals require additional precaution. Seek immediate medical attention for any allergic response, characterized by symptoms such as dyspnea, edema, or cutaneous eruptions.

Uses of Uroscan 76 Injection

Imaging contrast medium

Major Benefits of Uroscan 76 Injection:

Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Uroscan 76 Injection:

• Nausea
• Vomiting
• Vasodilation
• Paresthesia (tingling or pricking sensation)
• Dizziness
• Inflammation of the nose
• Cough
• Urticaria
• Injection site pain
• Painful erythematous swelling
• Taste change
• Osmotic nephrosis

How to use Uroscan 76 Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Uroscan 76 Injection works:

Uroscan 76 Injection, a dual-contrast agent containing meglumine diatrizoate and sodium diatrizoate, enhances visualization of internal organs during vascular imaging procedures. This aids in precise diagnostic assessments and contributes to proactive disease management.

What if you forget to take Uroscan 76 Injection :

NA